TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: placebo-corrected change from baseline QTcF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Glucose maximal concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Usability of the APP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline glaucomatous damage in the retina at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline visual fields at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline intraocular pressure at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Rates of re-tear
Endpoint domain: Adverse events/effects
Primary endpoint: Changes of vital signs in participants compared with baseline results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in laboratory values compared with baseline results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of BCMA CAR-T cell therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety and tolerability of CB06-036
Endpoint domain: Adverse events/effects
Primary endpoint: Bristol Breastfeeding Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Body composition (fat mass and free mass)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in level of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Transcriptome in white adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolome in fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of participants with adverse events by severity
Endpoint domain: Adverse events/effects
Primary endpoint: Caries Increment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Caries Incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Platelet engraftment on day 35 post HSCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Parental Comfort Providing Consent
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perioperative analgesia measured by Numeric Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of early treatment failure of the index ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the absolute lymphocyte count (ALC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: proportion of patients with adequate tissue for diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Time from intubation to extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total gonadotrophins dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from baseline in subjective sleep efficiency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from baseline in sleep efficiency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Concordance between RIA and calculated testosterone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Ileus resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in the number of adverse drug reactions (ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Health Eating Literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants With Freedom From SleepFlex-related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in the Apnea-hypopnea Index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: modified Rankin Scale (mRS) score at day 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Proportion of patients surviving with complete neurologic recovery
Endpoint domain: Mortality/survival
Primary endpoint: Internet Gaming Disorder Scale - short form
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximal mid-expiratory flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Results of Stroop Tests
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Boston Carpal Tunnel Syndrome Questionnaire Symptom Severity Scale (BCTQ-SSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in enacted, anticipated and internalized stigma towards HIV+ students
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in courtesy stigma towards HIV+ students
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in perceived stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite of all-cause mortality or hospitalization for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of dental dyschromia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beliefs, attitudes, and informational needs around gene therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive status assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Concentration of ketorolac in the vitreous humor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abdominal Bloating
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: EEG features associated with pediatric delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment emergent adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Children's Hope Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of symptomatic pandemic influenza
Endpoint domain: Adverse events/effects
Primary endpoint: Cycloplegic refractive error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early epithelialization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Granulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Outcome of surgical treatment of upper extremity lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: intraoperative opioid consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative opioid consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change of the damping coefficient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with SARI on mechanical ventilation for at least 5 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Renal tolerance by Glomerular filtration rate (GFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Digestive tolerance by ASAT, ALAT, gamma GT, lipase and amylase determination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient's Quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient's Self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjective tolerability of oral administration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cranio-horizontal angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sagittal shoulder posture angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed plasma concentration (Cmax) of BMS-986166
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from time zero to time of last quantifiable concentration (AUC(0-T)) of BMS-986166
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal plasma half-life (T-HALF) of BMS-986166
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reality-monitoring performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Profile of Moods Survey (POMS) Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Profile of Moods Survey (POMS) Vigor
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Profile of Moods Survey (POMS) Total Mood Disturbance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Troponin T AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Growth factors concentration in infant's plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytokines concentration in infant's plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Infant's gut microbiota occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: DLT-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Maximum Tolerable Dose (MTD) or Recommended Dose (RD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total morphine consumption within 24 hours postoperative
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in BPH symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade >= 3 treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: PrEP adherence as measured by tenofovir diphosphate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Infusion-related Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Change in contact lens discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility of the Mindfulness Intervention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Recorded critical incidents during the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: composite endpoint of any death, any stroke, systemic embolism, and BARC-defined bleeding events
Endpoint domain: Mortality/survival
Primary endpoint: Safety of TP53-R248Q TCR-T cell injection
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with treatment-related adverse events and toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Response to NK Cell treatment as determined by CT/MRI imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to NK Cell treatment as determined by MIBG scans imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to NK Cell treatment as determined by bone marrow aspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-sensitivity troponin T (hsTnT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum levels of 25(OH) Vitamin D3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Macrophage Migration Inhibitory Factor (MIF) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Adverse Events/Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of inflammation in the DL implant site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motivation and pleasure assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive and negative symptom assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive function measured by ADAS-Cog13
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Instrumental activities of daily living measured by ADCS-iADL
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of participants who complete all study procedures accordingly
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of screened patients eligible to participate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Brain-Derived Neurotrophic Factor (BDNF) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level during endometrial biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycaemic control (HbA1c level)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Noise nuisance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average change in Z-scores for memory and executive domain-related assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average change in Auditory Verbal Learning Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average change in Trail Making Test Part A and Part B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average change in Verbal Fluency Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average change in Boston Naming Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Preliminary clinical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor performance of infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adverse drug events at each dose level
Endpoint domain: Adverse events/effects
Primary endpoint: Smell Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smell Identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vicon 3D gait test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plantar fascia thickness measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ankle dorsiflexion angle measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: cerebral 18F-FDG PET-CT exam
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total number of drinks consumed in a typical week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Kessler-6 Psychological Distress Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients enrolled in clinical research
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Trough glucose while PN is suspended
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average glucose while receiving the target GIR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants with constitutional structural variants detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological response (PathR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One-year recurrence-free survival rate (RFS)
Endpoint domain: Mortality/survival
Primary endpoint: Overall survival (OS) after initial administration
Endpoint domain: Mortality/survival
Primary endpoint: Neck functional
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Neck Core stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Internet Addiction Test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hand Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pinch Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Usability scores of first VR intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability scores of second VR intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Appropriateness of study procedures for first VR intervention
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Appropriateness of study procedures for second VR intervention
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Mean monthly numbers of newly diagnosed gastric cancer patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clinical staging and pathologic TNM staging of the patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fatigue and post-exercise malaise
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Platelet levels of heat shock protein 47 (HSP47)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: adjudicated all-cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: adjudicated symptomatic recurrent VTE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: adjudicated major and clinically relevant non-major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Levels of salivary biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve (AUC) for glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC for C-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: non-displacable binding potential (BPND)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distribution volume ratio (DVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: comparison of cortical and white matter binding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of progressive cognitive decline
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Duration for the corneal surface to completely re-epithelialize
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade of postoperative corneal haze
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kujala questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: penile erection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RAVI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-1beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lifestyle Readiness to Change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confidence to Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area under curve for detecting stage I/II gastric cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of visits to the Emergency Reception Service
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of participants who experience a first episode of virologically-confirmed COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of participants reporting Serious adverse events or medically attended adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric mean of Anti-S IgG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean of SARS-CoV-2 serum neutralizing titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Comparative bioavailability of levodopa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timepoint of first unplanned re-hospitalization or death
Endpoint domain: Mortality/survival
Primary endpoint: Tidal volume generated by electromagnetical stimulation of the phrenic nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: F0 voice frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes